The significance of CCL22 and CCL17 is further affirmed in murine models of asthma, where the utilization of specific neutralising antibodies enables the reduction of airway hyperresponsiveness and allergic inflammation [50,51]. This evidence concerns the gene CCL22 and airway hyperresponsiveness.